Filing Details
- Accession Number:
- 0001438133-20-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-31 18:28:55
- Reporting Period:
- 2020-01-29
- Accepted Time:
- 2020-01-31 18:28:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1438133 | Tandem Diabetes Care Inc | TNDM | Surgical & Medical Instruments & Apparatus (3841) | 204327508 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1582779 | Dick Allen | C/O Tandem Diabetes Care, Inc., 11075 Roselle Street San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-01-29 | 1,671 | $11.06 | 1,671 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-01-29 | 1,671 | $75.56 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-01-29 | 1,700 | $19.00 | 1,700 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-01-29 | 1,700 | $76.00 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-01-29 | 5,300 | $2.59 | 5,300 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-01-29 | 5,300 | $75.95 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-01-29 | 1,700 | $2.54 | 1,700 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-01-29 | 1,700 | $76.15 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Stock Option | Common Stock | Disposition | 2020-01-29 | 1,671 | $0.00 | 1,671 | $11.06 |
Stock Option | Common Stock | Disposition | 2020-01-29 | 1,700 | $0.00 | 1,700 | $19.00 |
Stock Option | Common Stock | Disposition | 2020-01-29 | 5,300 | $0.00 | 5,300 | $2.59 |
Stock Option | Common Stock | Disposition | 2020-01-29 | 1,700 | $0.00 | 1,700 | $2.54 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct | ||
0 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 37,000 | Indirect | See Footnote |
Common Stock | 1,500 | Indirect | See Footnotes |
Common Stock | 1,500 | Indirect | See Footnote(s) |
Common Stock | 10,000 | Indirect | See Footnotes) |
Footnotes
- Represents shares of common stock received upon exercise of a stock option award.
- The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person August 22, 2019.
- The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $75.29 to $76.29. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $75.73 to $76.48. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $75.87 to $76.10. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $76.06 to $76.54. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The securities are held by the Allen Family Trust dated October 12, 1981.
- The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon.
- The securities are held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon.
- The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein.
- The option shall vest in equal monthly installments for a period of twenty-four(24) months.
- The expiration date for these options is 10 years from the date of grant.
- The option vested in twelve (12) equal monthly installments after one year from grant.